Sex and gender issues in multiple sclerosis

Therapeutic Advances in Neurological Disorders

Volumn 6, Issue 4, 2013, Pages 237-248

  Harbo, Hanne F ^a   Gold, Ralf ^b   Tintora, Mar ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b ST JOSEF HOSPITAL   (Germany)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

female; genes; immunology; Multiple sclerosis; pregnancy; sex

Indexed keywords

BETA INTERFERON; ESTRIOL; FINGOLIMOD; GONADORELIN ANTAGONIST; MITOXANTRONE; NATALIZUMAB; TERIFLUNOMIDE; VITAMIN D;

CLINICAL TRIAL (TOPIC); DISEASE PREDISPOSITION; DRUG EXPOSURE; ENVIRONMENTAL FACTOR; ESTROGEN THERAPY; GENDER AND SEX; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC SUSCEPTIBILITY; GYNECOMASTIA; HLA SYSTEM; HUMAN; IMMUNE SYSTEM; IMMUNOTHERAPY; INFERTILITY; INFERTILITY THERAPY; MICROCHIMERISM; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NONHUMAN; PATHOGENESIS; PHASE 2 CLINICAL TRIAL (TOPIC); PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW (TOPIC); TREATMENT RESPONSE; X CHROMOSOME;

EID: 84880339917     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285613488434     Document Type: Article

References (107)

1. Ahlgren C. Oden A. Lycke J. (2011) High nationwide prevalence of multiple sclerosis in Sweden. Mult Scler 17: 901–908.
2. Amato M. Portaccio E. Ghezzi A. Hakiki B. Zipoli V. Martinelli V. et al. (2010) Pregnancy and fetal outcomes after interferon-beta exposure in multiple sclerosis. Neurology 75: 1794–1802.
3. Ascherio A. Munger K. (2010) Epstein-Barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol 5: 271–277.
4. Ban M. Elson J. Walton A. Turnbull D. Compston A. Chinnery P. et al. (2008) Investigation of the role of mitochondrial DNA in multiple sclerosis susceptibility. PloS ONE 3: e2891.
5. Bebo B. Jr Zelinka-Vincent E. Adamus G. Amundson D. Vandenbark A. Offner H. (1998) Gonadal hormones influence the immune response to PLP 139–151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 84: 122–130.
6. Ben-Nun A. Wekerle H. Cohen I. (1981) The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 11: 195–199.
7. Bergamaschi R. (2007) Prognostic factors in multiple sclerosis. Int Rev Neurobiol 79: 423–447.
8. Boskovic R. Wide R. Wolpin J. Bauer D. Koren G. (2005) The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology 65: 807–811.
9. Bourre B. Marignier R. Zephir H. Papeix C. Brassat D. Castelnovo G. et al. (2012) Neuromyelitis optica and pregnancy. Neurology 78: 875–879.
10. Branch D. (1992) Physiologic adaptations of pregnancy. Am J Reprod Immunol 28: 120–122.
11. Celius E. Harbo H. Egeland T. Vartdal F. Vandvik B. Spurkiand A. (2000) Sex and age at diagnosis are correlated with the HLA-DR2, DQ 6 haplotype in multiple sclerosis. J Neurol Sci 178: 132–135.
12. Celius E. Smestad C. (2009) Change in sex ratio, disease course and age at diagnosis in Oslo MS patients through seven decades. Acta Neurol Scand Suppl (189): 27–29.
13. Comabella M. Vandenbroeck K. (2011) Pharmacogenomics and multiple sclerosis: moving toward individualized medicine. Curr Neurol Neurosci Rep 11: 484–491.
14. Compston A. Coles A. (2002) Multiple sclerosis. Lancet 359: 1221–1231.
15. Confavreux C. Hutchinson M. Hours M. Cortinovis-Tourniaire P. Moreau T. (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339: 285–291.
16. Correale J. Farez M. Ysrraelit M. (2012) Increase in multiple sclerosis activity after assisted reproduction technology. Ann Neurol 72: 682–694.
17. Correale J. Villa A. (2010) Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis. Ann Neurol 67: 625–638.
18. Cua D. Hinton D. Stohlman S. (1995) Self-antigen-induced Th 2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J Immunol 155: 4052–4059.
19. Dahl J. Myhr K. Daltveit A. Gilhus N. (2008) Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. J Neurol 255: 623–627.
20. Dahl J. Myhr K. Daltveit A. Hoff J. Gilhus N. (2005) Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology 65: 1961–1963.
21. Decard B. von A. Grunwald T. Streit F. Stroet A. Niggemeier P. et al. (2012) Low vitamin D and elevated immunoreactivity against Epstein–Barr virus before first clinical manifestation of multiple sclerosis. J Neurol Neurosurg Psychiatry 83: 1170–1173.
22. D'Hooghe M. Nagels G. Uitdehaag B. (2010) Long-term effects of childbirth in MS. J Neurol Neurosurg Psychiatry 81: 38–41.
23. Dyment D. Yee I. Ebers G. Sadovnick A. (2006) Multiple sclerosis in stepsiblings: recurrence risk and ascertainment. J Neurol Neurosurg Psychiatry 77: 258–259.
24. Ebers G. Sadovnick A. Risch N. (1995) A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377: 150–151.
25. Finkelsztejn A. Brooks J. Paschoal F. Jr Fragoso Y. (2011) What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 118: 790–797.
26. Fragoso Y. Boggild M. Macias-Islas M. Carra A. Schaerer K. Aguayo A. et al. (2013) The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis. Clin Neurol Neurosurg 115: 154–159.
27. Garay L. Deniselle M. Lima A. Roig P. de Nicola A. (2007) Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis. J Steroid Biochem Mol Biol 107: 228–237.
28. Gold R. Linington C. Lassmann H. (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129: 1953–1971.
29. Gold S. Voskuhl R. (2009) Estrogen and testosterone therapies in multiple sclerosis. Prog Brain Res 175: 239–251.
30. Gourraud P. Harbo H. Hauser S. Baranzini S. (2012) The genetics of multiple sclerosis: an up-to-date review. Immunol Rev 248: 87–103.
31. Greer J. McCombe P. (2011) Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuroimmunol 234: 7–18.
32. Gregg C. Zhang J. Butler J. Haig D. Dulac C. (2010) Sex-specific parent-of-origin allelic expression in the mouse brain. Science 329: 682–685.
33. Gross R. Healy B. Cepok S. Chitnis T. Khoury S. Hemmer B. et al. (2011) Population structure and HLA DRB 1 1501 in the response of subjects with multiple sclerosis to first-line treatments. J Neuroimmunol 233: 168–174.
34. Gutierrez-Roelens I. Lauwerys B. (2008) Genetic susceptibility to autoimmune disorders: clues from gene association and gene expression studies. Curr Mol Med 8: 551–561.
35. Hansen T. Skytthe A. Stenager E. Petersen H. Bronnum-Hansen H. Kyvik K. (2005) Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Mult Scler 11: 504–510.
36. Harbo H. Lie B. Sawcer S. Celius E. Dai K. Oturai A. et al. (2004) Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 63: 237–247.
37. Harbo H. Lorentzen A. Lie B. Celius E. Spurkland A. (2011) [New gene map for multiple sclerosis]. Tidsskr Nor Laegeforen 131: 2126–2130.
38. Healy B. Liguori M. Tran D. Chitnis T. Glanz B. Wolfish C. et al. (2010) HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology 75: 634–640.
39. Hellwig K. Haghikia A. Gold R. (2010) Parenthood and immunomodulation in patients with multiple sclerosis. J Neurol 257: 580–583.
40. Hellwig K. Haghikia A. Gold R. (2011 a) Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment. Mult Scler 17: 958–963.
41. Hellwig K. Schimrigk S. Chan A. Epplen J. Gold R. (2011 b) A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis. J Neurol Sci 307: 164–165.
42. Herrera B. Ramagopalan S. Lincoln M. Orton S. Chao M. Sadovnick A. et al. (2008) Parent-of-origin effects in MS: observations from avuncular pairs. Neurology 71: 799–803.
43. Imrell K. Greiner E. Hillert J. Masterman T. (2009) HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis. J Neuroimmunol 210: 128–130.
44. International Multiple Sclerosis Genetics Consortium (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357: 851–862.
45. Jalkanen A. Alanen A. Airas L. (2010) Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland. Mult Scler 16: 950–955.
46. Jersild C. Svejgaard A. Fog T. (1972) HL-A antigens and multiple sclerosis. Lancet 1: 1240–1241.
47. Jobin C. Larochelle C. Parpal H. Coyle P. Duquette P. (2010) Gender issues in multiple sclerosis: an update. Womens Health (Lond Engl) 6: 797–820.
48. Kampman M. Aarseth J. Grytten N. Benjaminsen E. Celius E. Dahl O. et al. (2013) Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway. J Neurol 6 January [Epub ahead of print].
49. Kantarci O. Hebrink D. Achenbach S. Atkinson E. De A. McMurray C. et al. (2004 a) CD95 polymorphisms are associated with susceptibility to MS in women. A population-based study of CD95 and CD95L in MS. J Neuroimmunol 146: 162–170.
50. Kantarci O. Hebrink D. Achenbach S. Pittock S. Altintas A. Schaefer-Klein J. et al. (2004 b) Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology 62: 811–814.
51. Kawakami N. Lassmann S. Li Z. Odoardi F. Ritter T. Ziemssen T. et al. (2004) The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J Exp Med 199: 185–197.
52. Kieseier et al. (2012) Abstract to ECTRIMS Congress, 2012.
53. Kim W. Kim S. Nakashima I. Takai Y. Fujihara K. Leite M. et al. (2012) Influence of pregnancy on neuromyelitis optica spectrum disorder. Neurology 78: 1264–1267.
54. Kleinewietfeld M. Manzel A. Titze J. Kvakan H. Yosef N. Linker R. et al. (2013) Sodium chloride drives autoimmune disease by the induction of pathogenic T 17 cells. Nature 496: 518–522.
55. Knudsen G. Harbo H. Smestad C. Celius E. Akesson E. Oturai A. et al. (2007) X chromosome inactivation in females with multiple sclerosis. Eur J Neurol 14: 1392–1396.
56. Koch-Henriksen N. Sorensen P. (2010 a) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9: 520–532.
57. Koch-Henriksen N. Sorensen P. (2010 b) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9: 520–532.
58. Kragt J. van A. Killestein J. Dijkstra C. Uitdehaag B. Polman C. et al. (2009) Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 15: 9–15.
59. Langer-Gould A. Huang S. Gupta R. Leimpeter A. Greenwood E. Albers K. et al. (2009) Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol 66: 958–963.
60. Langer-Gould A. Huang S. van Den Eeden S. Gupta R. Leimpeter A. Albers K. et al. (2011) Vitamin D, pregnancy, breastfeeding, and postpartum multiple sclerosis relapses. Arch Neurol 68: 310–313.
61. Link J. Kockum I. Lorentzen A. Lie B. Celius E. Westerlind H. et al. (2012) Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis. PloS ONE 7: e36779.
62. Lu E. Wang B. Guimond C. Synnes A. Sadovnick D. Tremlett H. (2012) Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review. Neurology 79: 1130–1135.
63. MacKenzie-Graham A. Rinek G. Avedisian A. Morales L. Umeda E. Boulat B. et al. (2012) Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis. J Neurosci Res 90: 1310–1323.
64. Masterman T. Ligers A. Olsson T. Andersson M. Olerup O. Hillert J. (2000) HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 48: 211–219.
65. McCombe P. Greer J. (2012) Female reproductive issues in multiple sclerosis. Mult Scler 25 June [Epub ahead of print].
66. Michel L. Foucher Y. Vukusic S. Confavreux C. de Sèze J. Brassat D. et al. (2012) Increased risk of multiple sclerosis relapse after in vitro fertilisation. J Neurol Neurosurg Psychiatry 83: 796–802.
67. Neuteboom R. Verbraak E. Voerman J. van Meurs M. Steegers E. de Groot C. et al. (2009) First trimester interleukin 8 levels are associated with postpartum relapse in multiple sclerosis. Mult Scler 15: 1356–1358.
68. Nielsen N. Jorgensen K. Stenager E. Jensen A. Pedersen B. Hjalgrim H. et al. (2011) Reproductive history and risk of multiple sclerosis. Epidemiology 22: 546–552.
69. Nielsen N. Westergaard T. Rostgaard K. Frisch M. Hjalgrim H. Wohlfahrt J. et al. (2005) Familial risk of multiple sclerosis: a nationwide cohort study. Am J Epidemiol 162: 774–778.
70. Oksenberg J. Baranzini S. Sawcer S. Hauser S. (2008) The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 9: 516–526.
71. Okuda D. Srinivasan R. Oksenberg J. Goodin D. Baranzini S. Beheshtian A. et al. (2009) Genotype–phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain 132: 250–259.
72. Olerup O. Hillert J. (1991) HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 38: 1–15.
73. Olsson J. Moller E. Link H. (1976) HLA haplotypes in families with high frequency of multiple sclerosis. Arch Neurol 33: 808–812.
74. Orton S. Ramagopalan S. Brocklebank D. Herrera B. Dyment D. Yee I. et al. (2010) Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study. J Neurol Neurosurg Psychiatry 81: 31–36.
75. Pakpoor J. Disanto G. Lacey M. Hellwig K. Giovannoni G. Ramagopalan S. (2012) Breastfeeding and multiple sclerosis relapses: a meta-analysis. J Neurol 259: 2246–2248.
76. Palaszynski K.M. Loo K.K. Ashouri J.F. Liu H.B. Voskuhl R.R. (2004) Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol 146(1-2):144–52.
77. Patsopoulos N. Esposito F. Reischl J. Lehr S. Bauer D. Heubach J. et al. (2011) Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 70: 897–912.
78. Ponsonby A. Lucas R. van der Mei I. Dear K. Valery P. Pender M. et al. (2012) Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study. Neurology 78: 867–874.
79. Robertson N. Fraser M. Deans J. Clayton D. Walker N. Compston D. (1996) Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 119 ( Pt 2):449–455.
80. Romero-Pinel L. Pujal J. Martinez-Yelamos S. Gubieras L. Matas E. Bau L. et al. (2011) HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population. Eur J Neurol 18: 337–342.
81. Saastamoinen K. Auvinen M. Tienari P. (2011) Month of birth is associated with multiple sclerosis but not with HLA-DR15 in Finland. Mult Scler 18: 563–568.
82. Saito S. Nakashima A. Shima T. Ito M. (2010) Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 63: 601–610.
83. Sandberg-Wollheim M. Alteri E. Moraga M. Kornmann G. (2011) Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy. Mult Scler 17: 423–430.
84. Sandberg-Wollheim M. Frank D. Goodwin T. Giesser B. Lopez-Bresnahan M. Stam-Moraga M. et al. (2005) Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology 65: 802–806.
85. Sawcer S. Hellenthal G. Pirinen M. Spencer C. Patsopoulos N. Moutsianas L. et al. (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214–219.
86. Sellebjerg F. Krakauer M. Khademi M. Olsson T. Sorensen P. (2012) FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis. Clin Exp Immunol 170: 149–155.
87. Selmi C. (2008) The X in sex: how autoimmune diseases revolve around sex chromosomes. Best Pract Res Clin Rheumatol 22: 913–922.
88. Simpson S. Jr Blizzard L. Otahal P. van der Mei I. Taylor B. (2011) Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 82: 1132–1141.
89. Smith-Bouvier D. Divekar A. Sasidhar M. Du S. Tiwari-Woodruff S. King J. et al. (2008) A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 205: 1099–1108.
90. Soldan S. Alvarez Retuerto A. Sicotte N. Voskuhl R. (2003) Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol 171: 6267–6274.
91. Spach K. Blake M. Bunn J. McElvany B. Noubade R. Blankenhorn E. et al. (2009) Cutting edge: the Y chromosome controls the age-dependent experimental allergic encephalomyelitis sexual dimorphism in SJL / J mice. J Immunol 182: 1789–1793.
92. Spach K. Hayes C. (2005) Vitamin D 3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175: 4119–4126.
93. Staples J. Ponsonby A. Lim L. (2010) Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis. BMJ 340: c1640.
94. Tafuri A. Alferink J. Moller P. Hammerling G. Arnold B. (1995) T cell awareness of paternal alloantigens during pregnancy. Science 270: 630–633.
95. Tai P. Wang J. Jin H. Song X. Yan J. Kang Y. et al. (2008) Induction of regulatory T cells by physiological level estrogen. J Cell Physiol 214: 456–464.
96. Trojano M. Lucchese G. Graziano G. Taylor B. Simpson S. Jr Lepore V. et al. (2012) Geographical variations in sex ratio trends over time in multiple sclerosis. PloS ONE 7: e48078.
97. Tselis A. (2011) Evidence for viral etiology of multiple sclerosis. Semin Neurol 31: 307–316.
98. van der Kop M. Pearce M. Dahlgren L. Synnes A. Sadovnick D. Sayao A. et al. (2011) Neonatal and delivery outcomes in women with multiple sclerosis. Ann Neurol 70: 41–50.
99. Voskuhl R. Gold S. (2012) Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol 8: 255–263.
100. Voskuhl R. Palaszynski K. (2001 a) Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 7: 258–270.
101. Voskuhl R. Palaszynski K. (2001 b) Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 7: 258–270.
102. Voskuhl R. Pitchekian-Halabi H. MacKenzie-Graham A. McFarland H. Raine C. (1996) Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann Neurol 39: 724–733.
103. Vukusic S. Hutchinson M. Hours M. Moreau T. Cortinovis-Tourniaire P. Adeleine P. et al. (2004) Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127: 1353–1360.
104. Wallin M. Culpepper W. Coffman P. Pulaski S. Maloni H. Mahan C. et al. (2012) The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service. Brain 135: 1778–1785.
105. Willer C. Dyment D. Risch N. Sadovnick A. Ebers G. (2003) Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A 100: 12877–12882.
106. Willer C. Sadovnick A. Ebers G. (2002) Microchimerism in autoimmunity and transplantation: potential relevance to multiple sclerosis. J Neuroimmunol 126: 126–133.
107. Zhang B. Walsh M. Nguyen K. Hillyard N. Cavanagh A. McCombe P. et al. (2003) Early pregnancy factor treatment suppresses the inflammatory response and adhesion molecule expression in the spinal cord of SJL / J mice with experimental autoimmune encephalomyelitis and the delayed-type hypersensitivity reaction to trinitrochlorobenzene in normal BALB / c mice. J Neurol Sci 212: 37–46.